These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 23772045

  • 1. Safety and tolerability of tigecycline for the treatment of complicated skin and soft-tissue and intra-abdominal infections: an analysis based on five European observational studies.
    Guirao X, Sánchez García M, Bassetti M, Bodmann KF, Dupont H, Montravers P, Heizmann WR, Capparella MR, Simoneau D, Eckmann C.
    J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii37-44. PubMed ID: 23772045
    [Abstract] [Full Text] [Related]

  • 2. Resistance mechanisms and epidemiology of multiresistant pathogens in Europe and efficacy of tigecycline in observational studies.
    Heizmann WR, Dupont H, Montravers P, Guirao X, Eckmann C, Bassetti M, García MS, Capparella MR, Simoneau D, Bodmann KF.
    J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii45-55. PubMed ID: 23772046
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of tigecycline for the treatment of complicated skin and soft-tissue infections in real-life clinical practice from five European observational studies.
    Montravers P, Bassetti M, Dupont H, Eckmann C, Heizmann WR, Guirao X, García MS, Capparella MR, Simoneau D, Bodmann KF.
    J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii15-24. PubMed ID: 23772042
    [Abstract] [Full Text] [Related]

  • 4. Prescription behaviours for tigecycline in real-life clinical practice from five European observational studies.
    Bassetti M, Eckmann C, Bodmann KF, Dupont H, Heizmann WR, Montravers P, Guirao X, Capparella MR, Simoneau D, Sánchez García M.
    J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii5-14. PubMed ID: 23772047
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Tigecycline: an antibiotic for the twenty-first century.
    Dryden M.
    J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii3-4. PubMed ID: 23772044
    [Abstract] [Full Text] [Related]

  • 9. Influence of age on the clinical efficacy of tigecycline in severely ill patients.
    Bassetti M, Guirao X, Montravers P, Rossolini GM, Sánchez García M, Sganga G, Eckmann C.
    J Glob Antimicrob Resist; 2019 Sep; 18():199-206. PubMed ID: 30953830
    [Abstract] [Full Text] [Related]

  • 10. Clinical response and mortality in tigecycline complicated intra-abdominal infection and complicated skin and soft-tissue infection trials.
    Bassetti M, McGovern PC, Wenisch C, Meyer RD, Yan JL, Wible M, Rottinghaus ST, Quintana A.
    Int J Antimicrob Agents; 2015 Sep; 46(3):346-50. PubMed ID: 26155003
    [Abstract] [Full Text] [Related]

  • 11. Prospective, non-interventional, multi-centre trial of tigecycline in the treatment of severely ill patients with complicated infections: new insights into clinical results and treatment practice.
    Eckmann C, Heizmann WR, Leitner E, von Eiff C, Bodmann KF.
    Chemotherapy; 2011 Sep; 57(4):275-84. PubMed ID: 21778715
    [Abstract] [Full Text] [Related]

  • 12. Tigecycline in the Treatment of Patients with Necrotizing Skin and Soft Tissue Infections Due to Multiresistant Bacteria.
    Eckmann C, Heizmann W, Bodmann KF, von Eiff C, Petrik C, Loeschmann PA.
    Surg Infect (Larchmt); 2015 Oct; 16(5):618-25. PubMed ID: 26115414
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Lucasti C, Jasovich A, Umeh O, Jiang J, Kaniga K, Friedland I.
    Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of tigecycline versus ceftriaxone plus metronidazole for the treatment of complicated intra-abdominal infections: results from a randomized, controlled trial.
    Qvist N, Warren B, Leister-Tebbe H, Zito ET, Pedersen R, McGovern PC, Babinchak T.
    Surg Infect (Larchmt); 2012 Apr; 13(2):102-9. PubMed ID: 22439781
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Current management of patients hospitalized with complicated skin and soft tissue infections across Europe (2010-2011): assessment of clinical practice patterns and real-life effectiveness of antibiotics from the REACH study.
    Garau J, Ostermann H, Medina J, Avila M, McBride K, Blasi F, REACH study group.
    Clin Microbiol Infect; 2013 Sep; 19(9):E377-85. PubMed ID: 23663184
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.